Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.

MLA

Capell, Hilary A., et al. “Combination Therapy with Sulfasalazine and Methotrexate Is More Effective than Either Drug Alone in Patients with Rheumatoid Arthritis with a Suboptimal Response to Sulfasalazine: Results from the Double-Blind Placebo-Controlled MASCOT Study.” Annals of the Rheumatic Diseases, vol. 66, no. 2, Feb. 2007, pp. 235–41. EBSCOhost, https://doi.org/10.1136/ard.2006.057133.

APA

Capell, H. A., Madhok, R., Porter, D. R., Munro, R. A. L., McInnes, I. B., Hunter, J. A., Steven, M., Zoma, A., Morrison, E., Sambrook, M., Wui Poon, F., Hampson, R., McDonald, F., Tierney, A., Henderson, N., & Ford, I. (2007). Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study. Annals of the Rheumatic Diseases, 66(2), 235–241. https://doi.org/10.1136/ard.2006.057133

Chicago

Capell, Hilary A, Rajan Madhok, Duncan R Porter, Robin A L Munro, Iain B McInnes, John A Hunter, Malcolm Steven, et al. 2007. “Combination Therapy with Sulfasalazine and Methotrexate Is More Effective than Either Drug Alone in Patients with Rheumatoid Arthritis with a Suboptimal Response to Sulfasalazine: Results from the Double-Blind Placebo-Controlled MASCOT Study.” Annals of the Rheumatic Diseases 66 (2): 235–41. doi:10.1136/ard.2006.057133.